A Clinical Approach of Renal Involvement in Granulomatosis with Polyangiitis

1. Couser W G . Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988; 11:44910.1016/S0272-6386(88)80079-9Search in Google Scholar

2. Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Crescentic glomerulonephritis. Heptinstall s Pathology of the Kidney, 5th edn 1988;625-656.Search in Google Scholar

3. Moutzouris L, Appel GB, et al. Renal biopsy in the very elderly. Clin J Am Soc 2009; 4:1073.10.2215/CJN.00990209Search in Google Scholar

4. Nair R, Bell JM, Walker PD. Renal biopsy in patients aged 80 years and older. Am J Kidney Dis 2004; 44:618.10.1016/S0272-6386(04)00944-8Search in Google Scholar

5. Kalluri R, Wilson CB, Weber M et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 1995; 6: 1178-1185.10.1681/ASN.V6411788589284Search in Google Scholar

6. Hellmark T, Johansson C, Wielander J. Characterization of anti-GMB antibodies involved in Goodpasture s syndrome. Kidney Int 1994; 46:823-839.10.1038/ki.1994.3387527877Search in Google Scholar

7. Niles JL, Bottinger EP, Saurina GRet al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996; 156:44010.1001/archinte.1996.00440040118013Search in Google Scholar

8. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63:1164.10.1046/j.1523-1755.2003.00843.x12631105Search in Google Scholar

9. Hellmark T, Niles JL,Collins AB, Brunmark C. Comparison of anti-GBM antibodies in area with or without ANCA . J Am Soc Nephrol 1997; 8: 376-38510.1681/ASN.V833769071706Search in Google Scholar

10. Baldwin DS. Kidney Int 1987; 31:790.Search in Google Scholar

11. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated. Am J Med 2004; 117:39.10.1016/j.amjmed.2004.02.03015210387Search in Google Scholar

12. Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis.Nephrol Dial Transplant 1998;13: S16-S20.10.1093/ndt/13.suppl_1.169507492Search in Google Scholar

13. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997; 337:1512-1523.10.1056/NEJM1997112033721069366584Search in Google Scholar

14. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis. Semin Diagnostic Pathol 2001; 18:3-13.Search in Google Scholar

15. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill Education; 2015: pp. 21842185.Search in Google Scholar

16. Tracy CL. Granulomatosis with Polyangiitis (Wegener Granulomatosis). In: Granulomatosis with Polyangiitis (Wegener Granulomatosis). New York, NY: WebMD. http://emedicine.medscape.com/article/332622-overview. Updated November 21, 2016. Accessed April 13, 2017.Search in Google Scholar

17. Falk RJ. Maintenance immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/maintenance-immunosuppressive-therapy-ingranulomatosis-with-polyangiitis-and-microscopic-polyangiitis. Last updated January 13, 2016. Accessed April 13, 2017.Search in Google Scholar

18. Merkel PA, Kaplan AA, Falk RJ. Initial immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/initial-immunosuppressive-therapy-in-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis. Last updated January 4, 2017. Accessed April 13, 2017Search in Google Scholar